Menu
GeneBe

PDE6A

phosphodiesterase 6A, the group of Phosphodiesterases

Basic information

Region (hg38): 5:149857952-149944793

Previous symbols: [ "PDEA" ]

Links

ENSG00000132915NCBI:5145OMIM:180071HGNC:8785Uniprot:P16499AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • retinitis pigmentosa (Supportive), mode of inheritance: AD
  • retinitis pigmentosa 43 (Strong), mode of inheritance: AR
  • retinitis pigmentosa 43 (Definitive), mode of inheritance: AR
  • inherited retinal dystrophy (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Retinitis pigmentosa 43ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingOphthalmologic7493036; 18723146; 21039428

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PDE6A gene.

  • not provided (675 variants)
  • Retinitis pigmentosa (177 variants)
  • Retinitis pigmentosa 43 (50 variants)
  • Inborn genetic diseases (47 variants)
  • Retinal dystrophy (29 variants)
  • not specified (19 variants)
  • Retinitis Pigmentosa, Recessive (11 variants)
  • Usher syndrome (2 variants)
  • PDE6A-related condition (2 variants)
  • Autosomal recessive retinitis pigmentosa (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDE6A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
109
clinvar
10
clinvar
122
missense
4
clinvar
4
clinvar
321
clinvar
7
clinvar
1
clinvar
337
nonsense
20
clinvar
5
clinvar
2
clinvar
27
start loss
1
clinvar
1
frameshift
21
clinvar
7
clinvar
5
clinvar
33
inframe indel
5
clinvar
1
clinvar
6
splice donor/acceptor (+/-2bp)
6
clinvar
15
clinvar
1
clinvar
22
splice region
19
23
2
44
non coding
62
clinvar
61
clinvar
29
clinvar
152
Total 51 31 400 178 40

Highest pathogenic variant AF is 0.0000657

Variants in PDE6A

This is a list of pathogenic ClinVar variants found in the PDE6A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-149858006-G-C Retinitis pigmentosa Uncertain significance (Jan 13, 2018)351936
5-149858042-G-C Retinitis pigmentosa Likely benign (Jan 12, 2018)351937
5-149858124-C-G Retinitis pigmentosa Benign (Jan 12, 2018)351938
5-149858126-T-G Retinitis pigmentosa Benign (Jan 12, 2018)351939
5-149858178-C-T Retinitis pigmentosa Uncertain significance (Jan 12, 2018)904357
5-149858233-T-C Retinitis pigmentosa Likely benign (Jan 13, 2018)351940
5-149858253-CCATAA-C Retinitis Pigmentosa, Recessive Uncertain significance (Jun 14, 2016)351941
5-149858269-G-C Retinitis pigmentosa Uncertain significance (Jan 13, 2018)351942
5-149858275-G-T Retinitis pigmentosa Uncertain significance (Jan 13, 2018)904358
5-149858279-C-T Retinitis pigmentosa Uncertain significance (Jan 13, 2018)904359
5-149858280-G-A Retinitis pigmentosa Uncertain significance (Jan 13, 2018)904360
5-149858313-A-G Retinitis pigmentosa Uncertain significance (Jan 12, 2018)904361
5-149858353-C-T Retinitis pigmentosa Benign (Jan 13, 2018)351943
5-149858370-T-G Retinitis pigmentosa Likely benign (Jan 13, 2018)905159
5-149858434-G-A Retinitis pigmentosa Uncertain significance (Jan 12, 2018)351944
5-149858495-C-T Retinitis pigmentosa Uncertain significance (Jan 13, 2018)905160
5-149858512-C-T Retinitis pigmentosa Uncertain significance (Jan 12, 2018)905161
5-149858559-G-A Retinitis pigmentosa Benign (Jan 13, 2018)351945
5-149858666-G-A Retinitis pigmentosa Likely benign (Jan 12, 2018)351946
5-149858701-C-T Retinitis pigmentosa Benign (Jan 13, 2018)351947
5-149858757-C-T Retinitis pigmentosa Uncertain significance (Jan 13, 2018)906747
5-149858785-T-C Retinitis pigmentosa Benign (Jan 12, 2018)351948
5-149858791-AAG-A Retinitis Pigmentosa, Recessive Uncertain significance (Jun 14, 2016)351949
5-149858814-ATC-A Retinitis Pigmentosa, Recessive Uncertain significance (Jun 14, 2016)351950
5-149858815-TC-T Retinitis Pigmentosa, Recessive Uncertain significance (Jun 14, 2016)351951

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PDE6Aprotein_codingprotein_codingENST00000255266 2286838
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
6.58e-250.0052512561401341257480.000533
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.4265044781.050.00002835789
Missense in Polyphen238217.141.09612654
Synonymous-0.1041831811.010.00001161506
Loss of Function0.8734147.50.8630.00000240560

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001030.00103
Ashkenazi Jewish0.000.00
East Asian0.001470.00147
Finnish0.0001420.000139
European (Non-Finnish)0.0004840.000484
Middle Eastern0.001470.00147
South Asian0.0006870.000621
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: This protein participates in processes of transmission and amplification of the visual signal.;
Disease
DISEASE: Retinitis pigmentosa 43 (RP43) [MIM:613810]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:10393062, ECO:0000269|PubMed:7493036}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Purine metabolism - Homo sapiens (human);Phototransduction - Homo sapiens (human);Phosphodiesterases in neuronal function;Signaling by GPCR;Signaling by WNT;Signal Transduction;visual signal transduction;Purine metabolism;Purine nucleotides nucleosides metabolism;Ca2+ pathway;Beta-catenin independent WNT signaling;Visual signal transduction: Rods;G alpha (i) signalling events;Activation of the phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;The phototransduction cascade;Visual phototransduction;GPCR downstream signalling (Consensus)

Recessive Scores

pRec
0.202

Intolerance Scores

loftool
0.543
rvis_EVS
-0.19
rvis_percentile_EVS
39.31

Haploinsufficiency Scores

pHI
0.390
hipred
N
hipred_score
0.322
ghis
0.409

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.476

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pde6a
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype;

Gene ontology

Biological process
G protein-coupled receptor signaling pathway;visual perception;rhodopsin mediated signaling pathway;regulation of rhodopsin mediated signaling pathway;regulation of cytosolic calcium ion concentration;retina development in camera-type eye
Cellular component
plasma membrane;photoreceptor disc membrane
Molecular function
metal ion binding;3',5'-cyclic-GMP phosphodiesterase activity